Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00958451 · ClinicalTrials.gov registry record · Phase 4
Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients
A Phase 4 study, sponsored by Salem Veterans Affairs Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
NCT00958451: Completed Phase 4 study, sponsored by Salem Veterans Affairs Medical Center.
NCT00958451 is a Phase 4 study that has completed, run by Salem Veterans Affairs Medical Center. The registered enrollment target is 80 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00958451, a Phase 4 study, has completed, sponsored by Salem Veterans Affairs Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
Study Summary
This is an open label, single center, randomized, active comparator controlled study, comparing the effects of vitamin D replacement using oral ergocalciferol versus paricalcitol on parathyroid hormone (PTH) levels in patients with stage 3 and 4 CKD and vitamin D deficiency or insufficiency. The purpose of this study is to determine which of these two approaches is more successful.
Interventions
- DRUG Paricalcitol
- DRUG Ergocalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-01 |
| Phase | Phase 4 |
What the finished NCT00958451 record still lists
NCT00958451 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which Paricalcitol is the first listed.
NCT00958451 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00958451 about?
NCT00958451 is a clinical study titled "Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients". This is an open label, single center, randomized, active comparator controlled study, comparing the effects of vitamin D replacement using oral ergocalciferol versus paricalcitol on parathyroid hormone (PTH) levels in patients with stage 3 and 4 CKD and vitamin D deficiency or insufficiency. The pur...
What is the current status of trial NCT00958451?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2009-07. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00958451?
The interventions under investigation include: Paricalcitol (DRUG), Ergocalciferol (DRUG).
Who is sponsoring clinical trial NCT00958451?
This trial is sponsored by Salem Veterans Affairs Medical Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00958451's enrollment target sits among peer trials
80 946th of 2000 higher than 1,021 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia